FANCD2: Difference between revisions

Jump to navigation Jump to search
m (Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}}))
(No difference)

Revision as of 17:16, 4 September 2012


Fanconi anemia, complementation group D2
Identifiers
Symbols FANCD2 ; FACD; FAD; FANCD; DKFZp762A223; FA-D2; FA4; FAD2; FLJ23826
External IDs Template:OMIM5 Template:MGI HomoloGene13212
Orthologs
Template:GNF Ortholog box
Species Human Mouse
Entrez n/a n/a
Ensembl n/a n/a
UniProt n/a n/a
RefSeq (mRNA) n/a n/a
RefSeq (protein) n/a n/a
Location (UCSC) n/a n/a
PubMed search n/a n/a

Fanconi anemia, complementation group D2, also known as FANCD2, is a human gene.[1]

The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, and FANCL. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group D2. This protein is monoubiquinated in response to DNA damage, resulting in its localization to nuclear foci with other proteins (BRCA1 AND BRCA2) involved in homology-directed DNA repair. Alternative splicing results in two transcript variants encoding different isoforms.[1]

References

  1. 1.0 1.1 "Entrez Gene: FANCD2 Fanconi anemia, complementation group D2".

Further reading

  • Whitney M, Thayer M, Reifsteck C; et al. (1995). "Microcell mediated chromosome transfer maps the Fanconi anaemia group D gene to chromosome 3p". Nat. Genet. 11 (3): 341–3. doi:10.1038/ng1195-341. PMID 7581463.
  • Hejna JA, Timmers CD, Reifsteck C; et al. (2000). "Localization of the Fanconi anemia complementation group D gene to a 200-kb region on chromosome 3p25.3". Am. J. Hum. Genet. 66 (5): 1540–51. PMID 10762542.
  • Timmers C, Taniguchi T, Hejna J; et al. (2001). "Positional cloning of a novel Fanconi anemia gene, FANCD2". Mol. Cell. 7 (2): 241–8. PMID 11239453.
  • Garcia-Higuera I, Taniguchi T, Ganesan S; et al. (2001). "Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway". Mol. Cell. 7 (2): 249–62. PMID 11239454.
  • Futaki M, Liu JM (2002). "Chromosomal breakage syndromes and the BRCA1 genome surveillance complex". Trends in molecular medicine. 7 (12): 560–5. PMID 11733219.
  • Wilson JB, Johnson MA, Stuckert AP; et al. (2002). "The Chinese hamster FANCG/XRCC9 mutant NM3 fails to express the monoubiquitinated form of the FANCD2 protein, is hypersensitive to a range of DNA damaging agents and exhibits a normal level of spontaneous sister chromatid exchange". Carcinogenesis. 22 (12): 1939–46. PMID 11751423.
  • Grompe M (2002). "FANCD2: a branch-point in DNA damage response?". Nat. Med. 8 (6): 555–6. doi:10.1038/nm0602-555. PMID 12042798.
  • Taniguchi T, Garcia-Higuera I, Xu B; et al. (2002). "Convergence of the fanconi anemia and ataxia telangiectasia signaling pathways". Cell. 109 (4): 459–72. PMID 12086603.
  • Pace P, Johnson M, Tan WM; et al. (2002). "FANCE: the link between Fanconi anaemia complex assembly and activity". EMBO J. 21 (13): 3414–23. doi:10.1093/emboj/cdf355. PMID 12093742.
  • Taniguchi T, Garcia-Higuera I, Andreassen PR; et al. (2002). "S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51". Blood. 100 (7): 2414–20. doi:10.1182/blood-2002-01-0278. PMID 12239151.
  • Tamary H, Bar-Yam R, Zemach M; et al. (2002). "The molecular biology of Fanconi anemia". Isr. Med. Assoc. J. 4 (10): 819–23. PMID 12389351.
  • Nakanishi K, Taniguchi T, Ranganathan V; et al. (2003). "Interaction of FANCD2 and NBS1 in the DNA damage response". Nat. Cell Biol. 4 (12): 913–20. doi:10.1038/ncb879. PMID 12447395.
  • Strausberg RL, Feingold EA, Grouse LH; et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMID 12477932.
  • Goldberg M, Stucki M, Falck J; et al. (2003). "MDC1 is required for the intra-S-phase DNA damage checkpoint". Nature. 421 (6926): 952–6. doi:10.1038/nature01445. PMID 12607003.
  • Stewart GS, Wang B, Bignell CR; et al. (2003). "MDC1 is a mediator of the mammalian DNA damage checkpoint". Nature. 421 (6926): 961–6. doi:10.1038/nature01446. PMID 12607005.
  • Gordon SM, Buchwald M (2003). "Fanconi anemia protein complex: mapping protein interactions in the yeast 2- and 3-hybrid systems". Blood. 102 (1): 136–41. doi:10.1182/blood-2002-11-3517. PMID 12649160.
  • Jin S, Mao H, Schnepp RW; et al. (2003). "Menin associates with FANCD2, a protein involved in repair of DNA damage". Cancer Res. 63 (14): 4204–10. PMID 12874027.
  • Vandenberg CJ, Gergely F, Ong CY; et al. (2003). "BRCA1-independent ubiquitination of FANCD2". Mol. Cell. 12 (1): 247–54. PMID 12887909.
  • Meetei AR, de Winter JP, Medhurst AL; et al. (2003). "A novel ubiquitin ligase is deficient in Fanconi anemia". Nat. Genet. 35 (2): 165–70. doi:10.1038/ng1241. PMID 12973351.
  • Reuter TY, Medhurst AL, Waisfisz Q; et al. (2003). "Yeast two-hybrid screens imply involvement of Fanconi anemia proteins in transcription regulation, cell signaling, oxidative metabolism, and cellular transport". Exp. Cell Res. 289 (2): 211–21. PMID 14499622.

Template:WikiDoc Sources